TY - JOUR
T1 - Combined Hyperglycemia and Hyperinsulinemia-induced Insulin Resistance in Adipocytes is associated with Dual Signaling Defects mediated by PKC-ζ
AU - Lu, Huogen
AU - Bogdanovic, Elena
AU - Yu, Zhiwen
AU - Cho, Charles
AU - Liu, Lijiang
AU - Ho, Karen
AU - Guo, June
AU - Yeung, Lucy S. N.
AU - Lehmann, Reiner
AU - Hundal, Harinder S.
AU - Giacca, Adria
AU - Fantus, I. George
N1 - This work was supported by a grant from the Canadian Institutes for Heath Research (CIHR, Grant No. 38009). EB and CC were supported in part by studentships from the Banting and Best Diabetes Centre, University of Toronto. LL was supported by a visiting Scholarship from the China Scholarship Council, China
PY - 2018/4/1
Y1 - 2018/4/1
N2 - A hyperglycemic and hyperinsulinemic environment characteristic of type 2 diabetes causes insulin resistance. In adipocytes, defects in both insulin sensitivity and maximum response of glucose transport have been demonstrated. To investigate the molecular mechanisms, freshly isolated rat adipocytes were incubated in control (5.6 mM glucose, no insulin) and high glucose (20 mM)/high insulin (100 nM) (HG/HI) for 18 h to induce insulin resistance. Insulin resistant adipocytes manifested decreased sensitivity of glucose uptake associated with defects in IRS-1 Tyr phosphorylation, association of p85 subunit of phosphatidylinositol-3-kinase, AktSer473 and Thr308 phosphorylation accompanied by impaired glucose transporter 4 translocation. In contrast, PKC-ζ activity was augmented by chronic HG/HI. Inhibition of PKC-ζ with a specific cell permeable peptide reversed the signalling defects and insulin sensitivity of glucose uptake. Transfection of dominant-negative kinase-inactive PKC-ζ blocked insulin resistance, while constitutively-active PKC-ζ recapitulated the defects. The HG/HI incubation was associated with stimulation of IRS-1Ser318 and AktThr34 phosphorylation, targets of PKC-ζ. Transfection of IRS-1S318A and AktT34A each partially corrected, while combined transfection of both completely normalized insulin signaling. In vivo hyperglycemia/hyperinsulinemia in rats, for 48h similarly resulted in activation of PKC-ζ and increased phosphorylation of IRS-1 Ser318 and AktThr 34. These data indicate that impairment of insulin signaling by chronic HG/HI is mediated by dual defects at IRS-1 and Akt mediated by PKC-ζ.
AB - A hyperglycemic and hyperinsulinemic environment characteristic of type 2 diabetes causes insulin resistance. In adipocytes, defects in both insulin sensitivity and maximum response of glucose transport have been demonstrated. To investigate the molecular mechanisms, freshly isolated rat adipocytes were incubated in control (5.6 mM glucose, no insulin) and high glucose (20 mM)/high insulin (100 nM) (HG/HI) for 18 h to induce insulin resistance. Insulin resistant adipocytes manifested decreased sensitivity of glucose uptake associated with defects in IRS-1 Tyr phosphorylation, association of p85 subunit of phosphatidylinositol-3-kinase, AktSer473 and Thr308 phosphorylation accompanied by impaired glucose transporter 4 translocation. In contrast, PKC-ζ activity was augmented by chronic HG/HI. Inhibition of PKC-ζ with a specific cell permeable peptide reversed the signalling defects and insulin sensitivity of glucose uptake. Transfection of dominant-negative kinase-inactive PKC-ζ blocked insulin resistance, while constitutively-active PKC-ζ recapitulated the defects. The HG/HI incubation was associated with stimulation of IRS-1Ser318 and AktThr34 phosphorylation, targets of PKC-ζ. Transfection of IRS-1S318A and AktT34A each partially corrected, while combined transfection of both completely normalized insulin signaling. In vivo hyperglycemia/hyperinsulinemia in rats, for 48h similarly resulted in activation of PKC-ζ and increased phosphorylation of IRS-1 Ser318 and AktThr 34. These data indicate that impairment of insulin signaling by chronic HG/HI is mediated by dual defects at IRS-1 and Akt mediated by PKC-ζ.
KW - Adipocytes/drug effects
KW - Animals
KW - Glucose/pharmacology
KW - Hyperglycemia/metabolism
KW - Hyperinsulinism/metabolism
KW - Insulin Receptor Substrate Proteins/metabolism
KW - Insulin Resistance/physiology
KW - Insulin/pharmacology
KW - Male
KW - Phosphatidylinositol 3-Kinases/metabolism
KW - Phosphorylation/drug effects
KW - Protein Kinase C/metabolism
KW - Rats
KW - Rats, Sprague-Dawley
KW - Signal Transduction/drug effects
U2 - 10.1210/en.2017-00312
DO - 10.1210/en.2017-00312
M3 - Article
C2 - 29370351
SN - 0013-7227
VL - 159
SP - 1658
EP - 1677
JO - Endocrinology
JF - Endocrinology
IS - 4
ER -